Pharmacotherapy of bipolar mixed states
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective: Mixed episodes comprise up to 40% of acute bipolar admissions. They are difficult‐to‐treat, complex clinical pictures. This review provides an overview of the available literature on the pharmacotherapy of manic‐depressive mixed states and suggests treatment options. Method: Literature was identified by searches in Medline, Embase and the Cochrane Controlled Trials Register. Studies were considered relevant if they contained the keywords mixed mania, mixed state(s), mixed episode(s), treatment, therapy, study or trial. Results: Overall, there were very few double‐blind, placebo‐controlled studies specifically designed to treat manic‐depressive mixed states. Rather, patients with mixed states comprised a sub‐group of the examined patient cohorts. Nevertheless, the data show that acute mixed states do not respond favourably to lithium. Instead, valproate and olanzapine are drugs of first choice. Carbamazepine may play a role in the prevention of mixed states. Antidepressants should be avoided, because they may worsen intraepisodic mood lability. Lamotrigine may be useful in treating mixed states with predominantly depressive symptoms. Conclusions: More treatment studies specifically designed to treat the complex clinical picture of mixed states are clearly needed. Current treatment recommendations for clinical practice based on the available literature can only target select aspects of these episodes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Olanzapine versus placebo in the treatment of acute mania
Tohen, M., Sanger, T. M., McElroy, S. L., Tollefson, G. D., Chengappa, K. N. R., Daniel, D. G., Petty, F., Centorrino, F., Wang, R., Grundy, S. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.702 · Cited by 585
Sachs, G. S., Grossman, F., Ghaemi, S. N., Okamoto, A., & Bowden, C. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1146 · Cited by 424
Yatham, L. N., Grossman, F., Augustyns, I., Vieta, E., & Ravindran, A. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.2.141 · Cited by 248
Differential Response to Lithium and Carbamazepine in the Prophylaxis of Bipolar Disorder
Greil, W., Kleindienst Nikolaus, D.-S., Erazo Natalia, D.-P., & Muller-Oerlinghausen, B. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00007 · Cited by 206
Barbosa, L., Berk, M., & Vorster, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0407 · Cited by 165
Zarate, C. A., & Tohen, M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.169 · Cited by 144
Kleindienst, N., & Greil, W. (2000) · Neuropsychobiology · doi:10.1159/000054844 · Cited by 123
Cited by
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“With regard to maintenance therapy, valproate appears to be more effective than lithium (Krüger et al., 2005), but the evidence regarding carbamazepine is equivocal.”
BackgroundPerugi, G., Medda, P., Toni, C., Mariani, M., Socci, C., & Mauri, M. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161017233642 · Cited by 167
“Treatment of MS is a therapeutic challenge mostly for the lower response to mood stabilizers, compared to pure manic or depressive episodes, and the actual necessity of drug combination [48].”
BackgroundBipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients
Valentí, M., Pacchiarotti, I., Rosa, A. R., Bonnín, C. M., Popovic, D., Nivoli, A. M. A., Murru, A., Grande, Í., Colom, F., & Vieta, E. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00908.x · Cited by 78
“The role of antidepressants (ADs) in the treatment of bipolar mixed episodes is highly controversial (9).”
BackgroundTreatment of mixed bipolar states
Fountoulakis, K. N., Kontis, D., Gonda, X., Siamouli, M., & Yatham, L. N. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001817 · Cited by 68
“Similarly, most treatment guidelines and recent reviews discourage clinicians from using an antidepressant in mixed bipolar disorder, but the evidence-based data supporting this are still limited (APA, 2002; Bauer et al. 1999; Kruger et al. 2005; Muzina, 2009 ; Sachs et al. 2000; Suppes et al. 2005).”
BackgroundResult
Metadata
- Authors
- Krüger, S., Trevor Young, L., & Bräunig, P.
- Venue
- Bipolar Disorders
- Publisher
- Wiley
- Published
- 2005-05-17
- Volume
- 7
- Issue
- 3
- Pages
- 205-215
- ISSN
- 1398-5647 (ISSN-L)
- 1399-5618
- OpenAlex
- W2093839512
- Cited by
- 68
- References
- 8
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacotherapy of bipolar mixed states. https://app.cochat.ai/papers/10.1111/j.1399-5618.2005.00197.x
- The paper
- Krüger, S., Trevor Young, L., & Bräunig, P. (2005). Pharmacotherapy of bipolar mixed states. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2005.00197.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.